SCHEMBL18878249

SCHEMBL18878249

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccc(-c5cccc6ccccc56)cc4)n3)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.57
▸ SMN1; SMN2 Q16637 3/20 0.57
▸ L3MBTL1 Q9Y468 2/20 0.57
▸ KDM4E B2RXH2 2/20 0.57
▸ ALDH1A1 P00352 2/20 0.57
▸ HPGD P15428 2/20 0.57
▸ MAPK1 P28482 2/20 0.57
▸ HSD17B10 Q99714 2/20 0.57
▸ ATM Q13315 2/20 0.57
▸ TP53 P04637 1/20 0.57
▸ TSHR P16473 1/20 0.57
▸ NFKB1 P19838 1/20 0.57
▸ NFKB2 Q00653 1/20 0.57
▸ RELA Q04206 1/20 0.57
▸ TDP1 Q9NUW8 1/20 0.57
▸ TNF P01375 1/20 0.53
▸ CA12 O43570 2/20 0.53
▸ CA1 P00915 2/20 0.53
▸ CA2 P00918 2/20 0.53
▸ CA9 Q16790 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23633533 1.00 MAPT (0.57) MAPTSMN1; SMN2L3MBTL1KDM4EALDH1A1
SCHEMBL10057486 1.00 MAPT (0.57) MAPTSMN1; SMN2L3MBTL1KDM4EALDH1A1
SCHEMBL27456160 1.00 MAPT (0.57) MAPTSMN1; SMN2L3MBTL1KDM4EALDH1A1
SCHEMBL13871690 1.00 MAPT (0.57) MAPTSMN1; SMN2L3MBTL1KDM4EALDH1A1
SCHEMBL13871689 1.00 MAPT (0.57) MAPTSMN1; SMN2L3MBTL1KDM4EALDH1A1
SCHEMBL29999229 0.98 MAPT (0.59) MAPTSMN1; SMN2L3MBTL1KDM4EALDH1A1
SCHEMBL24564910 0.98 MAPT (0.59) MAPTSMN1; SMN2L3MBTL1KDM4EALDH1A1
SCHEMBL18590073 0.98 MAPT (0.59) MAPTSMN1; SMN2L3MBTL1KDM4EALDH1A1
SCHEMBL23921204 0.96 MAPT (0.54) MAPTSMN1; SMN2L3MBTL1KDM4EALDH1A1
SCHEMBL27456265 0.96 MAPT (0.57) MAPTSMN1; SMN2L3MBTL1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024143905-A1 ORGANIC ELECTRIC ELEMENT USING ORGANIC ELECTRIC ELEMENT COMPOUND, AND ELECTRONIC DEVICE 덕산네오룩스 주식회사 2024-07-04 — — WO disclosed
US-20230292599-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO.,LTD. (KR) 2023-09-14 — — US disclosed
US-20230292599-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO.,LTD. (KR) 2023-09-14 — — US disclosed
EP-4201930-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT Materials Co., Ltd. (KR) 2023-06-28 — — EP disclosed
EP-3202872-A1 ORGANIC LIGHT EMITTING ELEMENT LG Chem, Ltd. (KR) 2017-08-09 — — EP disclosed
US-20170148995-A1 ORGANIC LIGHT EMITTING DISPLAY DEVICE LG DISPLAY CO., LTD. (KR) 2017-05-25 — — US disclosed
US-20170148995-A1 ORGANIC LIGHT EMITTING DISPLAY DEVICE LG DISPLAY CO., LTD. (KR) 2017-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230292599-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE CRY1, PPOX, ORC3 MAPT 376/4885SMN1; SMN2 2759/4885L3MBTL1 1170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback